A second protease in the R1 reagent further hydrolyzes the HbA1c sample to a glycated pentapeptide, which competes with the agglutinator (synthetic polymer containing multiple copies of the immunoreactive portion of A1c) for the anti-HbA1c antibody, thereby reducing the rate of agglutination.